glp-1 pharmacokinetics This figure schematically illustrates the time-dependent A Comprehensive Review on the

Rare cases of intestinal obstruction or ileus have been reported with these medications

Targeting the IL-6/JAK/STAT3 signalling axis in cancer

New research to be presented at the European Congress on Obesity (ECO 2025) suggests that weight loss treatments using GLP-1 and dual GLP-1/GIP receptor agonists can lead to significant fat loss with minimal reduction in lean muscle mass

Also, recent advances in molecular imaging have been useful in monitoring changes of pancreatic -cells, playing a significant role in diagnosing the disease and evaluating effectiveness of therapeutic interventions and islet transplantation

In clinical applications, in addition to treating T2DM, metformin has been found to be effective in certain diseases, such as obesity, cardiovascular disease, IBD, and other inflammation-related diseases

doi: 10.1016/j.bbrc.2006.09.033